# Nuvectis Pharma, Inc.: filings

NVCT · Nasdaq · CIK 1875558 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/nvct.md) · [Financials](/companies/nvct/financials.md) · [Filings](/companies/nvct/filings.md) · [Insiders](/companies/nvct/insiders.md)

## Reports and events: 70 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (4 128, 8-K 37, 10-Q 14, CORRESP 11, 3 9, SC 13G/A 7, S-1/A 6, UPLOAD 6, 10-K 5, 424B5 5, EFFECT 5, SC 13G 5, DEF 14A 4, FWP 4, DEFA14A 3, S-3 3, S-8 3, 4/A 2, S-1 2, SEC STAFF LETTER 2, 10-K/A 1, 424B4 1, 8-A12B 1, CERT 1, D 1, D/A 1, DRS 1, DRS/A 1, DRSLTR 1, S-1MEF 1, SC 13D 1, SCHEDULE 13G 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-08-21 | 16:31 ET | [8-K](/filings/0001104659-26-099712.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-26-099712 |
| 2026-08-04 | 09:01 ET | [10-Q](/filings/0001104659-26-090109.md) | Quarterly report, period 2026-06-30 | 0001104659-26-090109 |
| 2026-08-04 | 08:25 ET | [8-K](/filings/0001104659-26-090094.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-26-090094 |
| 2026-06-30 | 16:43 ET | [8-K](/filings/0001104659-26-079360.md) | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-26-079360 |
| 2026-06-29 | 16:07 ET | [8-K](/filings/0001104659-26-078823.md) | 8.01 Other events | 0001104659-26-078823 |
| 2026-06-23 | 07:00 ET | [8-K](/filings/0001104659-26-076624.md) | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-26-076624 |
| 2026-06-12 | 16:05 ET | [8-K](/filings/0001104659-26-073419.md) | 5.07 Shareholder vote results | 0001104659-26-073419 |
| 2026-05-05 | 09:03 ET | [10-Q](/filings/0001104659-26-055318.md) | Quarterly report, period 2026-03-31 | 0001104659-26-055318 |
| 2026-05-05 | 07:36 ET | [8-K](/filings/0001104659-26-055264.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-26-055264 |
| 2026-04-27 | 16:37 ET | [DEF 14A](/filings/0001104659-26-049476.md) | Proxy statement, period 2026-06-11 | 0001104659-26-049476 |
| 2026-02-11 | 08:10 ET | [8-K](/filings/0001104659-26-013049.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-26-013049 |
| 2026-02-11 | 08:02 ET | [10-K](/filings/0001104659-26-013044.md) | Annual report, period 2025-12-31 | 0001104659-26-013044 |
| 2025-11-04 | 08:16 ET | [8-K](/filings/0001104659-25-105953.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-25-105953 |
| 2025-11-04 | 08:01 ET | [10-Q](/filings/0001104659-25-105939.md) | Quarterly report, period 2025-09-30 | 0001104659-25-105939 |
| 2025-09-25 | 08:23 ET | [8-K](/filings/0001104659-25-093144.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001104659-25-093144 |
| 2025-08-05 | 09:30 ET | [10-Q](/filings/0001558370-25-010203.md) | Quarterly report, period 2025-06-30 | 0001558370-25-010203 |
| 2025-08-05 | 08:39 ET | [8-K](/filings/0001104659-25-073967.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-25-073967 |
| 2025-06-13 | 17:00 ET | [8-K](/filings/0001104659-25-059435.md) | 5.07 Shareholder vote results | 0001104659-25-059435 |
| 2025-05-09 | 17:20 ET | [8-K](/filings/0001104659-25-046845.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-25-046845 |
| 2025-05-06 | 16:12 ET | [10-Q](/filings/0001558370-25-006497.md) | Quarterly report, period 2025-03-31 | 0001558370-25-006497 |
| 2025-05-06 | 08:36 ET | [8-K](/filings/0001104659-25-044838.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-25-044838 |
| 2025-04-28 | 16:20 ET | [DEF 14A](/filings/0001104659-25-040225.md) | Proxy statement, period 2025-06-12 | 0001104659-25-040225 |
| 2025-02-25 | 16:05 ET | [10-K](/filings/0001558370-25-001496.md) | Annual report, period 2024-12-31 | 0001558370-25-001496 |
| 2025-02-25 | 09:26 ET | [8-K](/filings/0001104659-25-016779.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-25-016779 |
| 2025-02-06 | 21:51 ET | [8-K](/filings/0001104659-25-009813.md) | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-25-009813 |
| 2024-11-05 | 08:31 ET | [10-Q](/filings/0001558370-24-014340.md) | Quarterly report, period 2024-09-30 | 0001558370-24-014340 |
| 2024-11-05 | 07:08 ET | [8-K](/filings/0001104659-24-114097.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-24-114097 |
| 2024-08-29 | 08:52 ET | [8-K](/filings/0001104659-24-094609.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-24-094609 |
| 2024-08-06 | 09:20 ET | [10-Q](/filings/0001558370-24-010971.md) | Quarterly report, period 2024-06-30 | 0001558370-24-010971 |
| 2024-08-06 | 08:51 ET | [8-K](/filings/0001104659-24-086127.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-24-086127 |
| 2024-06-13 | 16:09 ET | [8-K](/filings/0001104659-24-071261.md) | 5.07 Shareholder vote results | 0001104659-24-071261 |
| 2024-05-07 | 16:30 ET | [10-Q](/filings/0001558370-24-007072.md) | Quarterly report, period 2024-03-31 | 0001558370-24-007072 |
| 2024-05-07 | 09:13 ET | [8-K](/filings/0001104659-24-057782.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-24-057782 |
| 2024-04-29 | 16:30 ET | [DEF 14A](/filings/0001104659-24-054082.md) | Proxy statement, period 2024-06-13 | 0001104659-24-054082 |
| 2024-03-05 | 17:20 ET | [10-K](/filings/0001558370-24-002497.md) | Annual report, period 2023-12-31 | 0001558370-24-002497 |
| 2024-03-05 | 08:17 ET | [8-K](/filings/0001104659-24-030773.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-24-030773 |
| 2023-11-08 | 08:39 ET | [8-K](/filings/0001104659-23-115538.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-23-115538 |
| 2023-11-08 | 07:45 ET | [10-Q](/filings/0001558370-23-018124.md) | Quarterly report, period 2023-09-30 | 0001558370-23-018124 |
| 2023-09-12 | 08:16 ET | [8-K](/filings/0001104659-23-099872.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-23-099872 |
| 2023-08-17 | 09:18 ET | [8-K](/filings/0001104659-23-092871.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-23-092871 |
| 2023-08-09 | 16:29 ET | [8-K](/filings/0001104659-23-089330.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-23-089330 |
| 2023-08-09 | 16:15 ET | [10-Q](/filings/0001558370-23-014266.md) | Quarterly report, period 2023-06-30 | 0001558370-23-014266 |
| 2023-07-03 | 08:00 ET | [8-K](/filings/0001104659-23-077410.md) | 2.02 Results of operations | 0001104659-23-077410 |
| 2023-06-16 | 16:45 ET | [8-K](/filings/0001104659-23-072304.md) | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001104659-23-072304 |
| 2023-05-15 | 08:22 ET | [8-K](/filings/0001104659-23-060239.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-23-060239 |
| 2023-05-10 | 16:30 ET | [10-Q](/filings/0001558370-23-009133.md) | Quarterly report, period 2023-03-31 | 0001558370-23-009133 |
| 2023-05-10 | 09:25 ET | [8-K](/filings/0001104659-23-058085.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-23-058085 |
| 2023-04-28 | 16:05 ET | [DEF 14A](/filings/0001104659-23-052907.md) | Proxy statement, period 2023-06-16 | 0001104659-23-052907 |
| 2023-03-27 | 08:31 ET | [10-K/A](/filings/0001104659-23-036896.md) | Annual report, amended, period 2022-12-31 | 0001104659-23-036896 |
| 2023-03-08 | 17:31 ET | [10-K](/filings/0001558370-23-003181.md) | Annual report, period 2022-12-31 | 0001558370-23-003181 |

Page 1 of 2. [Older](/companies/nvct/filings.md?page=2)
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:06 ET. No prices; not investment advice.